About Orchestra BioMed
Orchestra BioMed is a company based in New Hope (United States) founded in 2017 by Darren Sherman.. Orchestra BioMed has raised $205.88 million across 7 funding rounds from investors including Medtronic, SVB and Ligand Pharmaceuticals. The company has 70 employees as of December 31, 2024. Orchestra BioMed offers products and services including BackBeat CNT, Virtue SAB, and FreeHold Retractors. Orchestra BioMed operates in a competitive market with competitors including Biotronik, Inquis Medical, Spectrumedics, Synaptic Medical and Keku Medical, among others.
- Headquarter New Hope, United States
- Employees 70 as on 31 Dec, 2024
- Founders Darren Sherman
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orchestra Biomed Holdings, Inc.
-
Annual Revenue
$2.64 M-4.42as on Dec 31, 2024
-
Net Profit
$-61.02 M-24.23as on Dec 31, 2024
-
EBITDA
$-63.99 M-24.94as on Dec 31, 2024
-
Total Equity Funding
$205.88 M (USD)
in 7 rounds
-
Latest Funding Round
$35 M (USD), Post-IPO
Jul 31, 2025
-
Investors
Medtronic
& 7 more
-
Employee Count
70
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Orchestra BioMed
Orchestra BioMed is a publicly listed company on the NASDAQ with ticker symbol OBIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Orchestra BioMed
Orchestra BioMed offers a comprehensive portfolio of products and services, including BackBeat CNT, Virtue SAB, and FreeHold Retractors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational treatment for hypertension to reduce blood pressure persistently.
Balloon for artery disease treatment without permanent implants.
Devices for surgical procedures in medical settings.
Unlock access to complete
Unlock access to complete
Advisor Team
17 people
Leadership Team
12 people
Product Management Team
6 people
Software Development Team
4 people
Finance and Accounting
2 people
Sales and Marketing
2 people
Principal Team
2 people
Operations Team
2 people
Unlock access to complete
Funding Insights of Orchestra BioMed
Orchestra BioMed has successfully raised a total of $205.88M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $35 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $35.0M
-
First Round
First Round
(30 Jun 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Post-IPO - Orchestra BioMed | Valuation |
investors |
|
| Jul, 2022 | Amount | Series D - Orchestra BioMed | Valuation |
investors |
|
| Dec, 2019 | Amount | Debt – Venture - Orchestra BioMed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orchestra BioMed
Orchestra BioMed has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, SVB and Ligand Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
VC and investment banking firm backed by Aegis Capital Corp
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orchestra BioMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orchestra BioMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orchestra Biomed Comparisons
Competitors of Orchestra BioMed
Orchestra BioMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biotronik, Inquis Medical, Spectrumedics, Synaptic Medical and Keku Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular products and equipment are developed, manufactured, and distributed.
|
|
| domain | founded_year | HQ Location |
Developer of medical device for the treatment of peripheral thrombectomy
|
|
| domain | founded_year | HQ Location |
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac disease treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orchestra Biomed
Frequently Asked Questions about Orchestra BioMed
When was Orchestra BioMed founded?
Orchestra BioMed was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Orchestra BioMed located?
Orchestra BioMed is headquartered in New Hope, United States.
Is Orchestra BioMed a funded company?
Orchestra BioMed is a funded company, having raised a total of $205.88M across 7 funding rounds to date. The company's 1st funding round was a Debt – Venture of $20M, raised on Jun 30, 2018.
How many employees does Orchestra BioMed have?
As of Dec 31, 2024, the latest employee count at Orchestra BioMed is 70.
What is the annual revenue of Orchestra BioMed?
Annual revenue of Orchestra BioMed is $2.64M as on Dec 31, 2024.
What does Orchestra BioMed do?
Orchestra BioMed was founded in 2017 and is based in New Hope, United States. Medical devices addressing hypertension and atherosclerosis are developed within the cardiovascular sector. The product portfolio features the Virtue Sirolimus-Eluting Balloon, through which delayed-release sirolimus is delivered using bioabsorbable particles to prevent restenosis in arteries, alongside the BackBeat Cardiac Neuromodulation Therapy for targeted cardiac interventions.
Who are the top competitors of Orchestra BioMed?
Orchestra BioMed's top competitors include Biotronik, Inquis Medical and Spectrumedics.
What products or services does Orchestra BioMed offer?
Orchestra BioMed offers BackBeat CNT, Virtue SAB, and FreeHold Retractors.
Is Orchestra BioMed publicly traded?
Yes, Orchestra BioMed is publicly traded on NASDAQ under the ticker symbol OBIO.
Who are Orchestra BioMed's investors?
Orchestra BioMed has 8 investors. Key investors include Medtronic, SVB, Ligand Pharmaceuticals, RTW Investments, and Terumo Medical.
What is Orchestra BioMed's ticker symbol?
The ticker symbol of Orchestra BioMed is OBIO on NASDAQ.